MRI-based prognostic factors and risk stratification for treatment response in post-traumatic olfactory dysfunction
4 affiliations
- 1Chinese Academy of Medical Sciences & Peking Union Medical College
- 2Department of Otorhinolaryngology Head and Neck Surgery, China-Japan Friendship Hospital
- 3Department of Radiology, China-Japan Friendship Hospital
- 4Graduate School, Beijing University of Chinese Medicine
Abstract
Objective: To identify baseline magnetic resonance imaging (MRI) features associated with treatment response in post-traumatic olfactory dysfunction (PTOD) and to develop an exploratory MRI-based risk score.
Methods: This single-center retrospective cohort study included 41 patients with PTOD and 41 age- and sex-matched healthy controls. Olfactory bulb (OB) volume, morphology, and integrity, olfactory sulcus depth, and structural lesions in olfactory-related cortical regions were assessed on MRI. Olfactory function was evaluated using the Sniffin’ Sticks test, and treatment response was defined as an increase of ≥5.5 points in the Threshold-Discrimination-Identification score. Least absolute shrinkage and selection operator (LASSO) regression was used to select MRI features for model development, from which a simplified integer-based scoring system was derived.
Results: Compared with healthy controls, patients with PTOD had a shallower left olfactory sulcus and lower proportions of convex OB morphology bilaterally. After a median follow-up of 8 months, 16 of 41 patients (39.0%) met the treatment-response criterion. Three MRI features were retained in the LASSO model: left OB integrity, left orbital gyrus injury, and right temporal lobe injury. The resulting model had an apparent area under the receiver operating characteristic curve (AUC) of 0.885 (95% confidence interval [CI], 0.787–0.983). Full-pipeline internal validation yielded a stratified ten-fold cross-validated AUC of 0.733 (95% CI, 0.564–0.901) and a bootstrap optimism-corrected AUC of 0.725. The simplified three-factor scoring system had an apparent AUC of 0.869 (95% CI, 0.761–0.977) and a bootstrap bias-corrected AUC of 0.867, with treatment response rates of 75.0%, 50.0%, and 5.3% in the low-, intermediate-, and high-risk groups, respectively. The empirical MRI scoring scheme had an apparent AUC of 0.805 (95% CI, 0.662–0.926); the difference between the two scoring systems was not statistically significant (DeLong p = 0.079).
Conclusion: Baseline structural MRI features were associated with treatment response in PTOD. The exploratory three-factor MRI-based score showed potential for risk stratification within this cohort, but prospective external validation is required before clinical application.
Related
- Hemodynamic biomarkers in symptomatic intracranial atherosclerotic stenosis: evidence boundaries and research pathways from prognostic stratification to treatment-effect prediction
- Hydrogen gas and olfactory dysfunction in Alzheimer’s disease: the Hydrogen–Olfactory–Limbic hypothesis
- Facial Nerve Palsy With Olfactory and Gustatory Dysfunction Following COVID-19 Infection: An Illustrative Case-Based Narrative Review
- Olfactory dysfunction among gas station employees exposed to fuel vapors using digital odor identification testing
- Patient and Public Involvement in designing a clinical trial for the surgical management of persistent Post-Infectious Olfactory Dysfunction
BibTeX
@article{wang2026mribased,
title = {{MRI-based prognostic factors and risk stratification for treatment response in post-traumatic olfactory dysfunction}},
author = {Ziyi Wang and Yifan Li and Jixin Luan and Yihan Chen and Shanshan Zhang and Ruoqi Zhang and Tianyang Li and Shijia Wang and Haoyu Yang and Jianfeng Liu},
journal = {Frontiers in Neurology},
year = {2026},
month = oct,
doi = {10.3389/fneur.2026.1976254},
url = {https://www.frontiersin.org/articles/10.3389/fneur.2026.1976254/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - MRI-based prognostic factors and risk stratification for treatment response in post-traumatic olfactory dysfunction
AU - Ziyi Wang
AU - Yifan Li
AU - Jixin Luan
AU - Yihan Chen
AU - Shanshan Zhang
AU - Ruoqi Zhang
AU - Tianyang Li
AU - Shijia Wang
AU - Haoyu Yang
AU - Jianfeng Liu
PY - 2026
DA - 2026/10/29
JO - Frontiers in Neurology
DO - 10.3389/fneur.2026.1976254
UR - https://www.frontiersin.org/articles/10.3389/fneur.2026.1976254/full
AB - Objective: To identify baseline magnetic resonance imaging (MRI) features associated with treatment response in post-traumatic olfactory dysfunction (PTOD) and to develop an exploratory MRI-based risk score. Methods: This single-center retrospective cohort study included 41 patients with PTOD and 41 age- and sex-matched healthy controls. Olfactory bulb (OB) volume, morphology, and integrity, olfactory sulcus depth, and structural lesions in olfactory-related cortical regions were assessed on MRI. Olfactory function was evaluated using the Sniffin’ Sticks test, and treatment response was defined as an increase of ≥5.5 points in the Threshold-Discrimination-Identification score. Least absolute shrinkage and selection operator (LASSO) regression was used to select MRI features for model development, from which a simplified integer-based scoring system was derived. Results: Compared with healthy controls, patients with PTOD had a shallower left olfactory sulcus and lower proportions of convex OB morphology bilaterally. After a median follow-up of 8 months, 16 of 41 patients (39.0%) met the treatment-response criterion. Three MRI features were retained in the LASSO model: left OB integrity, left orbital gyrus injury, and right temporal lobe injury. The resulting model had an apparent area under the receiver operating characteristic curve (AUC) of 0.885 (95% confidence interval [CI], 0.787–0.983). Full-pipeline internal validation yielded a stratified ten-fold cross-validated AUC of 0.733 (95% CI, 0.564–0.901) and a bootstrap optimism-corrected AUC of 0.725. The simplified three-factor scoring system had an apparent AUC of 0.869 (95% CI, 0.761–0.977) and a bootstrap bias-corrected AUC of 0.867, with treatment response rates of 75.0%, 50.0%, and 5.3% in the low-, intermediate-, and high-risk groups, respectively. The empirical MRI scoring scheme had an apparent AUC of 0.805 (95% CI, 0.662–0.926); the difference between the two scoring systems was not statistically significant (DeLong p = 0.079). Conclusion: Baseline structural MRI features were associated with treatment response in PTOD. The exploratory three-factor MRI-based score showed potential for risk stratification within this cohort, but prospective external validation is required before clinical application.
SN - 1664-2295
ER -